Tricyclic-bridged piperidinylidene derivatives as delta opioid modulators
OwnerScott Dax, Bart DeCorte +3inventors
InventorsScott Dax, Bart DeCorte, Li Liu, Mark McDonnell, James McNally
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds, compositions and methods for treating various diseases and conditions, including pain. Such compounds are represented by Formula I as follows: wherein A, G, Y, R3, R4, and R5 are defined herein.
Claims118
A compound of Formula (I):
- wherein:
- G is —C(Z)NR1R2, C6-10aryl, C6-10arylthio, or a heterocycle selected from the group consisting of imidazolyl, triazolyl, tetrazolyl, oxadiazolyl, thiadiazolyl, oxathiadiazolyl, imidazolinyl, tetrahydropyrimidinyl, thienyl, pyrazolyl, pyrimidinyl, triazinyl, furyl, indazolyl, indolyl, indolinyl, isothiazolyl, isoxazolyl, oxazolyl, isoxadiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, and pyridinyl;
- wherein the C6-10aryl group in the C6-10aryl-containing substituents of G and the heterocycles of G are optionally substituted with one to three substituents independently selected from the group consisting of C1-8alkanyl, C2-8alkenyl, C2-8alkynyl, C1-8alkanyloxy, hydroxy(C1-6)alkanyl, carboxy(C1-6)alkanyl, C1-6alkanylcarbonylamino, halogen, hydroxy, cyano, nitro, oxo, thioxo, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-8alkanylthio, C1-8alkanylsulfonyl, C1-8alkanylsulfonylamino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, C1-8alkanylaminocarbonyl, di(C1-8alkanyl)aminocarbonyl, and C1-6alkanyloxycarbonylamino;
- R1 is a substituent selected from the group consisting of hydrogen, C1-8alkanyl, C2-8alkenyl, and C2-8alkynyl;
- R2 is a substituent selected from the group consisting of hydrogen;
- C1-8alkanyl;
- C2-8alkenyl;
- C2-8alkynyl;
- C6-10aryl;
- and C3-8cycloalkanyl;
- provided that when Z is O or S, R2 is other than hydrogen or unsubstituted C1-8alkanyl;
- and, wherein C1-8alkanyl of R2 is optionally substituted with one to three substituents independently selected from the group consisting of phenyl, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-6alkanyloxy, C1-6alkanylthio, hydroxy, fluoro, chloro, cyano, aminocarbonyl, C1-8alkanylaminocarbonyl, di(C1-8alkanyl)aminocarbonyl, C1-6alkanyloxycarbonyl, and aryloxy;
- wherein the phenyl and aryloxy substituents of C1-8alkanyl are further substituted with, and the C6-10aryl and C3-8cycloalkanyl substituents of R2 are optionally substituted with, one to three substituents independently selected from the group consisting of C1-8alkanyl, C2-8alkenyl, C2-8alkynyl, C1-8alkanyloxy, trifluoromethyl, trifluoromethoxy, phenyl, halogen, cyano, hydroxy, C1-8alkanylthio, C1-8alkanylsulfonyl, and C1-8alkanylsulfonylamino;
- or R1 and R2 taken together with the nitrogen to which they are attached form a 5-7 membered cycloheteroalkyl optionally substituted with phenyl (wherein phenyl is optionally substituted with one to three C1-4alkanyl or C1-4alkanyloxy substituents) and one to two additional substituents independently selected from the group consisting of C1-8alkanyl, hydroxy(C1-8)alkanyl, hydroxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, and halogen;
- or, R1 and R2 taken together with the nitrogen to which they are attached form a 5-7 membered cycloheteroalkyl optionally substituted with one to three substituents independently selected from the group consisting of C1-8alkanyl, hydroxy(C1-8)alkanyl, hydroxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, and halogen;
- R3 is a substituent selected from the group consisting of hydrogen, C1-8alkanyl, halo1-3(C1-8)alkanyl, C2-8alkenyl, C2-8alkynyl, C3-8cycloalkanyl, cycloalkanyl(C1-8)alkanyl, C1-8alkanyloxy(C1-8)alkanyl, C1-8alkanylthio(C1-8)alkanyl, hydroxyC1-8alkanyl, C1-8alkanyloxycarbonyl, halo1-3(C1-8)alkanylcarbonyl, formyl, thioformyl, carbamimidoyl, phenylimino(C1-8)alkanyl, phenyl(C1-8)alkanyl, phenyl(C1-8)alkenyl, phenyl(C1-8)alkynyl, naphthyl(C1-8)alkanyl and heteroaryl(C1-8)alkanyl wherein the heteroaryl is selected from the group consisting of benzo[1,3]dioxolyl, imidazolyl, furanyl, pyridinyl, thienyl, indazolyl, indolyl, indolinyl, isoindolinyl, isoquinolinyl, isothiazolyl, isoxazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyrimidinyl, pyrrolyl, quinolinyl, isoquinolinyl, tetrazolyl, thiazolyl;
- wherein phenyl, naphthyl, and heteroaryl are optionally substituted with one to three substituents independently selected from the group consisting of C1-6alkanyl, C2-6alkenyl, C1-6alkanyloxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-6alkanylcarbonyl, C1-6alkanylcarbonyloxy, C1-6alkanylcarbonylamino, C1-6alkanylthio, C1-6alkanylsulfonyl, halogen, hydroxy, cyano, fluoro(C1-6)alkanyl, thioureido, and fluoro(C1-6)alkanyloxy;
- alternatively, when phenyl and heteroaryl are optionally substituted with alkanyl or alkanyloxy substituents attached to adjacent carbon atoms, the two substituents can together form a fused cyclic alkanyl or cycloheteroalkanyl selected from the group consisting of —(CH2)3-5—, —O(CH2)2-4—, —(CH2)2-4O—, and —O(CH2)1-3O—;
- R4 is one to three substituents independently selected from the group consisting of hydrogen, C1-6alkanyl, C2-6alkenyl, C2-6alkynyl, aryl(C2-6)alkynyl, C1-6alkanyloxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-6alkanylcarbonyl, C1-6alkanylcarbonyloxy, C1-6alkanyloxycarbonyl, aminocarbonyl, C1-6alkanylaminocarbonyl, di(C1-6alkanyl)aminocarbonyl, C1-6alkanylcarbonylamino, C1-6alkanylthio, C1-6alkanylsulfonyl, halogen, hydroxy, mercapto, aminothiocarbonyl, amidino, hydroxyamidino, phenylcarbonyl, —C(═NOH)phenyl, aminomethyl, hydroxymethyl, methanesulfonylamino, C6-10arylamino (wherein C6-10aryl is optionally substituted with one to three substitutents independently selected from the group consisting of C1-6alkanyl, C1-6alkoxy, halogen, and hydroxy), dihydroimidazolyl, formylamino, thioformylamino, pyridinylamino, cyano, hydroxycarbonyl, C6-10aryl, chromanyl, chromenyl, furanyl, imidazolyl, indazolyl, indolyl, indolinyl, isoindolinyl, isoquinolinyl, isothiazolyl, isoxazolyl, naphthyridinyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl, quinolizinyl, quinoxalinyl, tetrazolyl, thiazolyl, thienyl, fluoroalkanyl and fluoroalkanyloxy;
- or optionally, when R4 is two substituents attached to adjacent carbon atoms, the two substituents together form a single fused moiety;
- wherein the fused moiety is selected from the group consisting of —(CH2)3-5—, —O(CH2)2-4—, —(CH2)2-4O—, —O(CH2)1-3O— and —S—C(NH2)═N—;
- R5 is one to two substituents independently selected from the group consisting of hydrogen, C1-6alkanyl, C2-6alkenyl, C1-6alkanyloxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-6alkanylcarbonyl, C1-6alkanylcarbonyloxy, C1-6alkanyloxycarbonyl, C1-6alkanylaminocarbonyl, C1-6alkanylcarbonylamino, C1-6alkanylthio, C1-6alkanylsulfonyl, halogen, hydroxy, cyano, fluoro(C1-6)alkanyl and fluoro(C1-6)alkanyloxy;
- A is (CH2)2;
- Y is S;
- X is O or S
- n is 0 or 1;
- Z is O, S, NH, N(C1-6alkanyl), N(OH), N(OC1-6alkanyl), or N(phenyl);
- and enantiomers, diastereomers, tautomers, solvates, or pharmaceutically acceptable salts thereof.
(canceled)
(canceled)
(canceled)
A compound of Formula (I):
- wherein:
- G is —C(Z)NR1R2, phenyl, or a heterocycle selected from the group consisting of imidazolyl, triazolyl, tetrazolyl, oxadiazolyl, thiadiazolyl, oxathiadiazolyl, imidazolinyl, tetrahydropyrimidinyl, thienyl, pyrazolyl, pyrimidinyl, triazinyl, furyl, isothiazolyl, isoxazolyl, oxazolyl, isoxadiazolyl, quinolinyl, and pyridinyl;
- wherein phenyl and the heterocycles of G are optionally substituted with one to three substituents independently selected from the group consisting of C1-8alkanyl, C1-8alkanyloxy, hydroxy(C1-8)alkanyl, carboxy(C1-8)alkanyl, C1-8alkanylcarbonylamino, halogen, hydroxy, cyano, oxo, thioxo, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-8alkanylthio, aminocarbonyl, aminothiocarbonyl, C1-8alkanylaminocarbonyl, di(C1-8alkanyl)aminocarbonyl, and C1-6alkanyloxycarbonylamino;
- R1 is hydrogen or C1-4alkanyl;
- R2 is selected from the group consisting of hydrogen;
- C1-4alkanyl;
- phenyl;
- and C3-6cycloalkanyl;
- provided that when Z is O or S, R2 is other than hydrogen or unsubstituted C1-4alkanyl;
- and, wherein C1-4alkanyl is optionally substituted with one to three substituents independently selected from the group consisting of phenyl, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-4alkanyloxy, hydroxy, fluoro, chloro, cyano, aminocarbonyl, C1-8alkanylaminocarbonyl, di(C1-8alkanyl)aminocarbonyl, and phenoxy;
- wherein the phenyl and phenoxy substituents of C1-4alkanyl are optionally further substituted with, and the phenyl and C3-6cycloalkanyl substituents of R2 are optionally substituted with, one to three substituents independently selected from the group consisting of C1-8alkanyl, C1-8alkanyloxy, trifluoromethyl, phenyl, fluoro, hydroxy, C1-8alkanylthio, C1-8alkanylsulfonyl, and C1-8alkanylsulfonylamino;
- or R1 and R2 taken together with the nitrogen to which they are attached form a 5-7 membered cycloheteroalkyl optionally substituted with phenyl (wherein phenyl is optionally substituted with C1-4alkanyloxy or hydroxy), C1-4alkanyl, or hydroxy;
- R3 is selected from the group consisting of hydrogen, C1-8alkanyl, C2-8alkenyl, C2-8alkynyl, C1-8alkanyloxy(C1-8)alkanyl, C1-8alkanylthio(C1-8)alkanyl, hydroxyC1-8alkanyl, thioformyl, phenylimino(C1-8)alkanyl, phenyl(C1-8)alkanyl, and heteroaryl(C1-8)alkanyl wherein heteroaryl is selected from the group consisting of benzo[1,3]dioxolyl, imidazolyl, furanyl, pyridinyl, thienyl, indolyl, indolinyl, isoquinolinyl, pyrazinyl, pyrazolyl, pyridazinyl, pyrimidinyl, pyrrolyl, quinolinyl, isoquinolinyl, tetrazolyl;
- wherein phenyl and heteroaryl are optionally substituted with one to three substituents independently selected from the group consisting of C1-6alkanyloxy and hydroxy;
- or optionally, when phenyl and heteroaryl are optionally substituted with two substituents attached to adjacent carbon atoms, the two substituents together form a single fused moiety;
- wherein the moiety is selected from —O(CH2)1-3O—;
- R4 is one to three substituents independently selected from the group consisting of hydrogen, C1-6alkanyl, C1-6alkanyloxy, aminocarbonyl, aminothiocarbonyl, hydroxyamidino, formylamino, C1-6alkanylaminocarbonyl, C1-6alkanylcarbonylamino, halogen, hydroxy, C6-10aryl, chromanyl, chromenyl, furanyl, imidazolyl, indazolyl, indolyl, indolinyl, isoindolinyl, isoquinolinyl, isothiazolyl, isoxazolyl, naphthyridinyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl, quinolizinyl, quinoxalinyl, tetrazolyl, thiazolyl, and thienyl;
- R5 is one to two substituents independently selected from the group consisting of hydrogen and halogen;
- A is —(CH2)2—;
- Y is;
- Z is O, NH, N(C1-6alkanyl), N(OH), N(OC1-6alkanyl), or N(phenyl);
- and
- enantiomers, diastereomers, tautomers, solvates, and pharmaceutically acceptable salts thereof.
A compound of Formula (I):
- wherein:
- G is —C(Z)NR1R2, phenyl, or a heterocycle selected from the group consisting of imidazolyl, tetrazolyl, oxadiazolyl, thiadiazolyl, oxathiadiazolyl, imidazolinyl, thienyl, pyrazolyl, pyrimidinyl, triazinyl, furyl, isothiazolyl, isoxazolyl, oxazolyl, isoxadiazolyl, quinolinyl, and pyridinyl;
- wherein phenyl and the heterocycles of G are optionally substituted with one to three substituents independently selected from the group consisting of C1-4alkanyl, C1-4alkanyloxy, hydroxy(C1-4)alkanyl, carboxy(C1-4)alkanyl, C1-4alkanylcarbonylamino, hydroxy, cyano, oxo, thioxo, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-8alkanylthio, aminocarbonyl, aminothiocarbonyl, C1-8alkanylaminocarbonyl, and di(C1-8alkanyl)aminocarbonyl;
- R1 is selected from the group consisting of hydrogen, methyl, ethyl, and propyl;
- R2 is selected from the group consisting of C1-4alkanyl, phenyl, and C3-6cycloalkanyl;
- provided that when Z is O or S, R2 is other than unsubstituted C1-4alkanyl;
- and, wherein C1-4alkanyl is optionally substituted with one to three substituents independently selected from the group consisting of phenyl, C1-4alkanyloxy, hydroxy, fluoro, aminocarbonyl, C1-8alkanylaminocarbonyl, di(C1-8alkanyl)aminocarbonyl, and phenoxy;
- wherein the phenyl and phenoxy substituents of C1-4alkanyl are optionally further substituted with, and the phenyl of R2 is optionally substituted with, one to three substituents independently selected from the group consisting of C1-6alkanyl, C1-6alkanyloxy, fluoro, hydroxy, and C1-6alkanylthio;
- or R1 and R2 taken together with the nitrogen to which they are attached form pyrrolidinyl or piperidinyl ring wherein said pyrrolidinyl or piperidinyl is optionally substituted with a substituent selected from the group consisting of C1-3alkanyl and hydroxy;
- R3 is selected from the group consisting of hydrogen, methyl, allyl, 2-methyl-allyl, propynyl, hydroxyethyl, methylthioethyl, methoxyethyl, thioformyl, phenyliminomethyl, phenethyl, and heteroaryl(C1-8)alkanyl wherein the heteroaryl is selected from the group consisting of benzo[1,3]dioxolyl, imidazolyl, furanyl, pyridinyl, thienyl, pyrimidinyl, pyrrolyl, quinolinyl, isoquinolinyl, tetrazolyl;
- wherein the phenyl in any phenyl-containing substituent is optionally substituted with one hydroxyl group;
- R4 is one to two substituents independently selected from the group consisting of hydrogen, C1-4alkanyl, C1-4alkanyloxy, halogen, phenyl, furanyl, imidazolyl, indazolyl, indolyl, indolinyl, isoindolinyl, isoquinolinyl, isothiazolyl, isoxazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinolinyl, tetrazolyl, thiazolyl, thienyl, hydroxy, and aminocarbonyl;
- R5 is hydrogen;
- A is —(CH2)2—;
- Y is S;
- Z is O, NH, or N(OH);
- and
- enantiomers, diastereomers, tautomers, solvates, and pharmaceutically acceptable salts thereof.
A compound of Formula (I):
- wherein:
- G is selected from —C(Z)NR1R2, 2-methylcarbonylaminophenyl, 2-aminocarbonyl-phenyl, 1H-tetrazol-5-yl, 2-methyl-tetrazol-5-yl, 4H-[1,2,4]-oxadiazol-5-oxo-3-yl, 4H-[1,2,4]-oxadiazol-5-thioxo-3-yl, 4H-[1,2,4]thiadiazol-5-oxo-3-yl, [1,2,3,5]oxathiadiazol-2-oxo-4-yl, or pyridin-3-yl;
- R1 is hydrogen, methyl, or ethyl;
- R2 is selected from the group consisting of C1-4alkanyl and phenyl;
- provided that when Z is O or S, R2 is other than unsubstituted C1-4alkanyl;
- and, wherein C1-4alkanyl is optionally substituted with one to three substituents independently selected from the group consisting of phenyl, C1-4alkanyloxy, hydroxy, fluoro, and phenoxy;
- wherein the phenyl and phenoxy substituents of C1-4alkanyl are optionally further substituted with, and the phenyl of R2 is optionally substituted with, one to three substituents independently selected from the group consisting of C1-6alkanyl, C1-6alkanyloxy, fluoro, and hydroxy;
- or R1 and R2 taken together with the nitrogen to which they are attached form a pyrrolidinyl or piperidinyl ring wherein said pyrrolidinyl or piperidinyl is optionally substituted with a substituent selected from C1-3alkanyl or hydroxy;
- R3 is selected from the group consisting of hydrogen, methyl, allyl, 2-methyl-allyl, propynyl, hydroxyethyl, methylthioethyl, methoxyethyl, thioformyl, phenyliminomethyl, phenethyl, and heteroaryl(C1-8)alkanyl wherein the heteroaryl is selected from the group consisting of benzo[1,3]dioxolyl, imidazolyl, furanyl, pyridinyl, thienyl, pyrimidinyl, pyrrolyl, quinolinyl, isoquinolinyl, tetrazolyl;
- wherein the phenyl in any phenyl-containing substituent is optionally substituted with one hydroxyl group;
- R4 is one to three substituents independently selected from the group consisting of hydrogen, C1-4alkanyl, C1-4alkanyloxy, halogen, phenyl, furanyl, imidazolyl, indazolyl, indolyl, indolinyl, isoindolinyl, isoquinolinyl, isothiazolyl, isoxazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinolinyl, tetrazolyl, thiazolyl, thienyl, hydroxy, and aminocarbonyl;
- R5 is hydrogen;
- A is —(CH2)2—;
- Y is S;
- Z is O or NH;
- and
- enantiomers, diastereomers, tautomers, solvates, and pharmaceutically acceptable salts thereof.
A compound of Formula (I):
- selected from the group consisting of:
- a compound of Formula (I) wherein G is phenylthio;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 1H-tetrazol-5-yl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 1H-tetrazol-5-yl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is methyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is 1H-imidazol-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is fur-3-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is pyridin-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is methyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is 1H-imidazol-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is fur-3-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- and
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is pyridin-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S.
A compound of Formula (I):
- selected from the group consisting of:
- a compound of Formula (I) wherein G is 1H-tetrazol-5-yl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 1H-tetrazol-5-yl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is methyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is 1H-imidazol-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is fur-3-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is pyridin-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is 1H-imidazol-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is fur-3-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- and
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is pyridin-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S.
A compound of Formula (I):
- selected from the group consisting of:
- a compound of Formula (I) wherein G is 1H-tetrazol-5-yl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 1H-tetrazol-5-yl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is 1H-imidazol-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is fur-3-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is pyridin-3-yl;
- R3 is pyridin-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is fur-3-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S;
- and
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is pyridin-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S.
A compound of Formula (I):
- selected from the group consisting of:
- a compound of Formula (I) wherein G is 1H-tetrazol-5-yl;
- R3 is H;
- R3 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (I) wherein G is 1H-tetrazol-5-yl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- and
- a compound of Formula (I) wherein G is 2-methylcarbonylamino-phenyl;
- R3 is pyridin-2-ylmethyl;
- R4 is H;
- R5 is H;
- and Y is S.
A compound of Formula (Ib):
- selected from the group consisting of:
- a compound of Formula (Ib) wherein G is methoxycarbonyl;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- a compound of Formula (Ib) wherein G is bromo;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S;
- and
- a compound of Formula (Ib) wherein G is cyano;
- R3 is H;
- R4 is H;
- R5 is H;
- and Y is S.
A composition comprising the dextrorotatory enantiomer of a compound of formula (I) wherein said composition is substantially free from the levorotatory isomer of said compound.
A composition comprising the levororotatory enantiomer of a compound of formula (I) wherein said composition is substantially free from the dextrorotatory isomer of said compound.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A compound of Formula (Ib):
- wherein:
- G is bromo, chloro, cyano, trifluoromethanesulfonyloxy, C1-8alkanyloxycarbonyl, carboxy, —C(Z)NR1R2, C6-10aryl, C6-10arylthio, or a heterocycle selected from the group consisting of imidazolyl, triazolyl, tetrazolyl, oxadiazolyl, thiadiazolyl, oxathiadiazolyl, imidazolinyl, tetrahydropyrimidinyl, thienyl, pyrazolyl, pyrimidinyl, triazinyl, furyl, indazolyl, indolyl, indolinyl, isothiazolyl, isoxazolyl, oxazolyl, isoxadiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, and pyridinyl;
- wherein the C6-10aryl group in the C6-10aryl-containing substituents of G and the heterocycles of G are optionally substituted with one to three substituents independently selected from the group consisting of C1-8alkanyl, C2-8alkenyl, C2-8alkynyl, C1-8alkanyloxy, hydroxy(C1-8)alkanyl, carboxy(C1-8)alkanyl, C1-8alkanylcarbonylamino, halogen, hydroxy, cyano, nitro, oxo, thioxo, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-8alkanylthio, C1-8alkanylsulfonyl, C1-8alkanylsulfonylamino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, C1-8alkanylaminocarbonyl, di(C1-8alkanyl)aminocarbonyl, and C1-6alkanyloxycarbonylamino;
- R1 is a substituent selected from the group consisting of hydrogen, C1-8alkanyl, C2-8alkenyl, and C2-8alkynyl;
- R2 is a substituent selected from the group consisting of hydrogen;
- C1-8alkanyl;
- C2-8alkenyl;
- C2-8alkynyl;
- C6-10aryl;
- and C3-8cycloalkanyl;
- provided that when Z is O or S, R2 is other than hydrogen or unsubstituted C1-8alkanyl;
- and, wherein C1-8alkanyl of R2 is optionally substituted with one to three substituents independently selected from the group consisting of phenyl, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-6alkanyloxy, C1-6alkanylthio, hydroxy, fluoro, chloro, cyano, aminocarbonyl, C1-8alkanylaminocarbonyl, di(C1-8alkanyl)aminocarbonyl, C1-6alkanyloxycarbonyl, and aryloxy;
- wherein the phenyl and aryloxy substituents of C1-8alkanyl are optionally further substituted with, and the C6-10aryl and C3-8cycloalkanyl substituents of R2 are optionally substituted with, one to three substituents independently selected from the group consisting of C1-8alkanyl, C2-8alkenyl, C2-8alkynyl, C1-8alkanyloxy, trifluoromethyl, trifluoromethoxy, phenyl, halogen, cyano, hydroxy, C1-8alkanylthio, C1-8alkanylsulfonyl, and C1-8alkanylsulfonylamino;
- or R1 and R2 taken together with the nitrogen to which they are attached form a 5-7 membered cycloheteroalkyl optionally substituted with phenyl (wherein phenyl is optionally substituted with one to three C1-4alkanyl or C1-4alkanyloxy substituents) and one to two additional substituents independently selected from the group consisting of C1-8alkanyl, hydroxy(C1-8)alkanyl, hydroxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, and halogen;
- or, R1 and R2 taken together with the nitrogen to which they are attached form a 5-7 membered cycloheteroalkyl optionally substituted with one to three substituents independently selected from the group consisting of C1-8alkanyl, hydroxy(C1-8)alkanyl, hydroxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, and halogen;
- R3 is a substituent selected from the group consisting of hydrogen, C1-8alkanyl, halo1-3(C1-8)alkanyl, C2-8alkenyl, C2-8alkynyl, C3-8cycloalkanyl, cycloalkanyl(C1-8)alkanyl, C1-8alkanyloxy(C1-8)alkanyl, C1-8alkanylthio(C1-8)alkanyl, hydroxyC1-8alkanyl, C1-8alkanyloxycarbonyl, halo1-3(C1-8)alkanylcarbonyl, formyl, thioformyl, carbamimidoyl, phenylimino(C1-8)alkanyl, phenyl(C1-8)alkanyl, phenyl(C1-8)alkenyl, phenyl(C1-8)alkynyl, naphthyl(C1-8)alkanyl and heteroaryl(C1-8)alkanyl wherein the heteroaryl is selected from the group consisting of benzo[1,3]dioxolyl, imidazolyl, furanyl, pyridinyl, thienyl, indazolyl, indolyl, indolinyl, isoindolinyl, isoquinolinyl, isothiazolyl, isoxazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyrimidinyl, pyrrolyl, quinolinyl, isoquinolinyl, tetrazolyl, thiazolyl;
- wherein phenyl, naphthyl and heteroaryl are optionally substituted with one to three substituents independently selected from the group consisting of C1-6alkanyl, C2-6alkenyl, C1-6alkanyloxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-6alkanylcarbonyl, C1-6alkanylcarbonyloxy, C1-6alkanylcarbonylamino, C1-6alkanylthio, C1-6alkanylsulfonyl, halogen, hydroxy, cyano, fluoro(C1-6)alkanyl, thioureido, and fluoro(C1-6)alkanyloxy;
- alternatively, when phenyl and heteroaryl are optionally substituted with alkanyl or alkanyloxy substituents attached to adjacent carbon atoms, the two substituents can together form a fused cyclic alkanyl or cycloheteroalkanyl selected from the group consisting of —(CH2)3-5—, —O(CH2)2-4—, —(CH2)2-4O—, and —O(CH2)1-3O—;
- R4 is one to three substituents independently selected from the group consisting of hydrogen, C1-6alkanyl, C2-6alkenyl, C2-6alkynyl, aryl(C2-6)alkynyl, C1-6alkanyloxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-6alkanylcarbonyl, C1-6alkanylcarbonyloxy, C1-6alkanyloxycarbonyl, aminocarbonyl, C1-6alkanylaminocarbonyl, di(C1-6alkanyl)aminocarbonyl, C1-6alkanylcarbonylamino, C1-6alkanylthio, C1-6alkanylsulfonyl, halogen, hydroxy, mercapto, aminothiocarbonyl, amidino, hydroxyamidino, phenylcarbonyl, —C(═NOH)phenyl, aminomethyl, hydroxymethyl, methanesulfonylamino, C6-10arylamino (wherein C6-10aryl is optionally substituted with one to three substitutents independently selected from the group consisting of C1-6alkanyl, C1-6alkoxy, halogen, and hydroxy), dihydroimidazolyl, formylamino, thioformylamino, pyridinylamino, cyano, hydroxycarbonyl, C6-10aryl, chromanyl, chromenyl, furanyl, imidazolyl, indazolyl, indolyl, indolinyl, isoindolinyl, isoquinolinyl, isothiazolyl, isoxazolyl, naphthyridinyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl, quinolizinyl, quinoxalinyl, tetrazolyl, thiazolyl, thienyl, fluoroalkanyl and fluoroalkanyloxy;
- or optionally, when R4 is two substituents attached to adjacent carbon atoms, the two substituents together form a single fused moiety;
- wherein the fused moiety is selected from the group consisting of —(CH2)3-5—, —O(CH2)2-4—, —(CH2)2-4O—, —O(CH2)1-3O— and —S—C(NH2)═N—;
- R5 is one to two substituents independently selected from the group consisting of hydrogen, C1-6alkanyl, C2-6alkenyl, C1-6alkanyloxy, amino, C1-6alkanylamino, di(C1-6alkanyl)amino, C1-6alkanylcarbonyl, C1-6alkanylcarbonyloxy, C1-6alkanyloxycarbonyl, C1-6alkanylaminocarbonyl, C1-6alkanylcarbonylamino, C1-6alkanylthio, C1-6alkanylsulfonyl, halogen, hydroxy, cyano, fluoro(C1-6)alkanyl and fluoro(C1-6)alkanyloxy;
- A (CH2)2;
- Y is S;
- X is O or S
- n is 0 or 1;
- Z is O, S, NH, N(C1-6alkanyl), N(OH), N(OC1-6alkanyl), or N(phenyl);
- and enantiomers, diastereomers, tautomers, solvates, or pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.